NASDAW:EDGE Long Term Shareholder Notice: Investigation of Potential Wrongdoing by Edge Therapeutics, Inc.
Certain directors of Edge Therapeutics, Inc. (NASDAW:EDGE) are under investigation over potential breaches of fiduciary duties.
View full press release